Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Antoni Ribas's publication output changed over time?
ScholarIQpublication output · 2011–2018
Output grew100% over the shown period — from 1 works in 2011 to 2 in 2018.
1
1
1
2
1
2
2
2
20112012201320142015201620172018
What are the most-cited papers on Antoni Ribas?
ScholarIQmost cited works
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, John B.A.G. Haanen, Paolo A. Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio, David Hogg, Paul Lorigan, Célèste Lebbé, Thomas Jouary, Dirk Schadendorf, Antoni Ribas, Steven O’Day, Jeffrey A. Sosman, John M. Kirkwood, Alexander M.M. Eggermont, Brigitte Dréno, K. B. Nolop, Jiang Li, B. Nelson, Jeannie Hou, Richard J. Lee, Keith T. Flaherty, Grant A. McArthur
New England Journal of Medicine. 20117,715 CitationsOPEN ACCESS
Cancer immunotherapy using checkpoint blockade
Antoni Ribas, Jedd D. Wolchok
Science. 20186,800 CitationsOPEN ACCESS
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, I. Peter Shintaku, Emma Taylor, Lídia Robert, Bartosz Chmielowski, Marko Spasić, Gina Henry, Voicu Ciobanu, Alisha N. West, Manuel Carmona, Christine Kivork, Elizabeth Seja, Grace Cherry, Antonio Gutiérrez, Tristan Grogan, Christine Mateus, Gorana Tomasic, John A. Glaspy, Ryan Emerson, Harlan Robins, Robert H. Pierce, David Elashoff, Caroline Robert, Antoni Ribas
Nature. 20146,675 CitationsOPEN ACCESS
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Jean‐Jacques Grob, Laurent Mortier, Adil Daud, Matteo S. Carlino, Catriona M. McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian U. Blank, Omid Hamid, Christine Mateus, Ronnie Shapira‐Frommer, Michele Kosh, Honghong Zhou, Nageatte Ibrahim, Scot Ebbinghaus, Antoni Ribas
New England Journal of Medicine. 20155,885 CitationsOPEN ACCESS
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo, Antoni Ribas
Cell. 20175,542 CitationsOPEN ACCESS
Related on ScholarIQ
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paper
Cancer immunotherapy using checkpoint blockade
Paper
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paper
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Paper
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Paper
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Paper